Table 3.
Results of the clinical and functional assessment of patients; baseline versus posttreatment
| Variable | Time of observation | L group | US group |
|---|---|---|---|
| Hand grip strength (kg), mean value±SD | Baseline | 23.0±3.9 | 22.8±3.6 |
| Posttreatment | 24.9±3.3 | 24.7±2.8 | |
| P | 0.03† | 0.01† | |
| VAS (mean±SD) | Baseline | 5.9±1.4 | 6.0±1.3 |
| Posttreatment | 3.6±2.1 | 3.4±1.7 | |
| P | 0.01† | 0.01† | |
| Positive phalen’s test, n (%)* | Baseline | 26 (74.3) | 27 (77.1) |
| Posttreatment | 19 (54.3) | 18 (51.4) | |
| P | 0.08 | 0.03† | |
| Positive tinel’s sign, n (%)* | Baseline | 18 (51.4) | 21 (56.7) |
| Posttreatment | 12 (34.3) | 15 (42.9) | |
| P | 0.15 | 0.28 | |
| CTS SSS (mean±SD) | Baseline | 3.0±0.7 | 3.2±0.6 |
| Posttreatment | 2.2±0.7 | 2.3±0.6 | |
| P | 0.01† | 0.01† | |
| CTS FSS (mean±SD) | Baseline | 3.0±0.8 | 3.1±0.7 |
| Posttreatment | 2.3±0.8 | 2.2±0.7 | |
| P | 0.01† | 0.01† |
*Number of wrists, †P<0.05 - statistically significant difference. SD=Standard deviation, CTS=Carpal tunnel syndrome, SSS=Symptom severity scale, FSS=Functional status scale, VAS=Visual analog scale